Literature DB >> 11229778

Aminoglycoside antibiotics, neamine and its derivatives as potent inhibitors for the RNA-protein interactions derived from HIV-1 activators.

K Hamasaki1, A Ueno.   

Abstract

Neamine derivatives which have an arginine (RN), a pyrene (PCN) and both pyrene and arginine (PRN) have been prepared and their binding toward the RNA fragments derived from HIV-1 activator region, TAR and RRE RNA were examined. Among them, PRN bound either TAR RNA or RRE RNA with equivalent binding affinities as Tat and Rev peptide, respectively.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11229778     DOI: 10.1016/s0960-894x(01)00005-1

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  11 in total

1.  Quantitative Studies of an RNA Duplex Electrostatics by Ion Counting.

Authors:  Magdalena Gebala; Daniel Herschlag
Journal:  Biophys J       Date:  2019-08-12       Impact factor: 4.033

2.  A reporter based single step assay for evaluation of inhibitors targeting HIV-1 Rev-RRE interaction.

Authors:  Sumeer Raina; Ajit G Chande; Masanori Baba; Robin Mukhopadhyaya
Journal:  Virusdisease       Date:  2013-09-27

3.  The use of aminoglycoside derivatives to study the mechanism of aminoglycoside 6'-N-acetyltransferase and the role of 6'-NH2 in antibacterial activity.

Authors:  Xuxu Yan; Feng Gao; Sirilata Yotphan; Parseh Bakirtzian; Karine Auclair
Journal:  Bioorg Med Chem       Date:  2007-02-11       Impact factor: 3.641

4.  FRET enabled real time detection of RNA-small molecule binding.

Authors:  Yun Xie; Andrew V Dix; Yitzhak Tor
Journal:  J Am Chem Soc       Date:  2009-12-09       Impact factor: 15.419

5.  Heterocyclic compounds that inhibit Rev-RRE function and human immunodeficiency virus type 1 replication.

Authors:  Deidra Shuck-Lee; Fei Fei Chen; Ryan Willard; Sharmila Raman; Roger Ptak; Marie-Louise Hammarskjold; David Rekosh
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

6.  Characterization and in vitro activity of a branched peptide boronic acid that interacts with HIV-1 RRE RNA.

Authors:  Jessica E Wynn; Wenyu Zhang; Denis M Tebit; Laurie R Gray; Marie-Louise Hammarskjold; David Rekosh; Webster L Santos
Journal:  Bioorg Med Chem       Date:  2016-04-05       Impact factor: 3.641

7.  Targeting folded RNA: a branched peptide boronic acid that binds to a large surface area of HIV-1 RRE RNA.

Authors:  Wenyu Zhang; David I Bryson; Jason B Crumpton; Jessica Wynn; Webster L Santos
Journal:  Org Biomol Chem       Date:  2013-10-07       Impact factor: 3.876

8.  Impact of Tat Genetic Variation on HIV-1 Disease.

Authors:  Luna Li; Satinder Dahiya; Sandhya Kortagere; Benjamas Aiamkitsumrit; David Cunningham; Vanessa Pirrone; Michael R Nonnemacher; Brian Wigdahl
Journal:  Adv Virol       Date:  2012-07-30

9.  Strategies to Block HIV Transcription: Focus on Small Molecule Tat Inhibitors.

Authors:  Guillaume Mousseau; Susana Valente
Journal:  Biology (Basel)       Date:  2012-11-19

10.  Understanding the characteristics of nonspecific binding of drug-like compounds to canonical stem-loop RNAs and their implications for functional cellular assays.

Authors:  Megan L Kelly; Chia-Chieh Chu; Honglue Shi; Laura R Ganser; Hal P Bogerd; Kelly Huynh; Yuze Hou; Bryan R Cullen; Hashim M Al-Hashimi
Journal:  RNA       Date:  2020-10-07       Impact factor: 5.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.